Obtaining Technetium-99m-Labeled Glucose Derivatives
Shranjeno v:
| Parent link: | Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 567-571] |
|---|---|
| Drugi avtorji: | , , , |
| Izvleček: | Title screen The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC). Режим доступа: по договору с организацией-держателем ресурса |
| Jezik: | angleščina |
| Izdano: |
2015
|
| Serija: | Radiation Technologies in Medicine |
| Teme: | |
| Online dostop: | http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.567 |
| Format: | Elektronski Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640463 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
| Izvleček: | Title screen The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC). Режим доступа: по договору с организацией-держателем ресурса |
|---|---|
| DOI: | 10.4028/www.scientific.net/AMR.1084.567 |